不那么快:在持续监测葡萄糖的小鼠中,由于食物撤回,葡萄糖耐受性测试的变异性矛盾地增加了
William B Rubio1, Marissa D Cortopassi1, Deepti Ramachandran1
1Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Molecular metabolism
|August 28, 2023
概括
在葡萄糖耐受性测试之前禁食小鼠可以悖论地增加变异性. 短暂的禁食会引起压力,而长时间的禁食会导致昏迷,这既会扭曲结果,又会影响葡萄糖代谢.
科学领域:
- 代谢研究研究 代谢研究
- 动物模型 动物模型
- 临床前研究 临床前研究
背景情况:
- 禁食通常用于临床前动物模型,以减少代谢参数的个体间变化.
- 个体在养行为上的变化需要禁食来进行代谢和行为实验.
- 禁食引起的压力可能会扭曲实验变量,包括葡萄糖耐受性测试 (GTT) 的结果.
研究的目的:
- 为了确定禁食时间对小鼠葡萄糖耐受性测试 (GTT) 复制性的影响.
- 在临床前模型中调查禁食如何影响葡萄糖代谢和动物间的变异性.
- 评估禁食引起的压力和生理状态对GTT反应的影响.
主要方法:
- 在成年雄性小鼠中使用了4周的同时持续血糖监测 (CGM) 和间接热量计.
- 数量化血糖,体力活动,体温,新陈代谢率和每分钟的食物消耗.
- 在光/黑暗光周期期间,在GTT上测试了4小时或18小时的禁食效果,有或没有CGM.
主要成果:
- 在光明时期的4小时禁食,矛盾地增加了动物之间的代谢率,活性,温度和葡萄糖耐受性的变化.
- 这种高血糖和高代谢的表型与皮质的增加相关,表明对食物剥夺的压力反应.
- 一个18小时快速诱导的,以低体温和代谢率为特征,与显著降低的葡萄糖水平,影响GTT反应.
结论:
- 在葡萄糖耐受性测试前禁食小鼠可以增加实验变异性,这与预期的效果相反.
- 短期禁食引起的压力和长期禁食引起的麻木都会对GTT的可重现性产生负面影响.
- 这些发现建议重新考虑GTT和其他临床前实验的禁食协议,以避免引入偏见.
更多相关视频
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
14.2K
03:25Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
5.6K
相关概念视频
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
